Shukra Pharmaceuticals standalone net profit rises 975.00% in the June 2022 quarter

9 Aug 2022 , 05:02 PM

Net profit of Shukra Pharmaceuticals rose 975.00% to Rs 0.43 crore in the quarter ended June 2022 as against Rs 0.04 crore during the previous quarter ended June 2021. Sales rose 121.96% to Rs 6.57 crore in the quarter ended June 2022 as against Rs 2.96 crore during the previous quarter ended June 2021.

Particulars	Quarter Ended
?	Jun. 2022	Jun. 2021	% Var.
Sales	6.57	2.96	122
OPM %	14.61	7.09	–
PBDT	0.85	0.42	102
PBT	0.43	0.05	760
NP	0.43	0.04	975

Powered by Capital Market – Live News